MODERN VIEW ON THE DIAGNOSTICS AND THERAPY OF POSTSTROKE DEPRESSIONS


R.V. Akhapkin1, 2, N.V. Mironova2

(1) SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH, Moscow (2) FSBI “Federal Medical Research Center for Psychiatry and Narcology n.a. V.P. Serbsky” of RMH, Moscow
The article presents an overview of current data on epidemiology and pathogenesis, risk factors and adverse effects, diagnosis and therapy of poststroke depressions. Antidepressants used to treat poststroke depressions are considered separately for each class of drugs. The main domestic and foreign clinical guidelines for the diagnosis and therapy of poststroke depressions are discussed.

About the Autors


Corresponding author: R.V. Akhapkin – PhD, psychiatrist at the SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH, Head of the Department of New Drugs and Methods of Therapy of the Division of Boundary Psychiatry FSBI FMRCPN n.a. V.P. Serbsky of RMH, Moscow; e-mail: 4ahapkin@gmail.com


Similar Articles


Бионика Медиа